INNA-051 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-03-12 in 4mo
ESTIMATED |
READOUT
A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing R
Phase 2 · Viral Respiratory Infection, Viral Respiratory Illnesses |
ENA Respiratory Pty Ltd | INNA-051 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-11-02
Sponsor-projected date — can change
|